Announcements Trials
Browse Landscape

Phase

Phase NA 35Phase 2 7Phase 3 5Phase 4 2Phase 1 2Phase EARLY_PHASE1 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1Genitourinary 1

Conditions

Prostatic Intraepithelial Neoplasia 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cyclophosphamide 624pembrolizumab 500Paclitaxel 456Gemcitabine 438Carboplatin 435Cisplatin 418Radiotherapy 380fludarabine 365Nivolumab 340Docetaxel 277Bevacizumab 276Irinotecan 257Magnetic Resonance Spectroscopy 242Fluorouracil 228Dexamethasone 225Specimen Handling 221Capecitabine 218Rituximab 205Cytarabine 201Oxaliplatin 200Ipilimumab 199Temozolomide 197Biopsy 196fludarabine phosphate 194Etoposide 181Lenalidomide 176Doxorubicin 175Leucovorin 173Cetuximab 171Injections 170

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Interventional × Dietary Supplements × Clear all
NCT06566443 2025-06-17

Honokiol in Early-Stage Resectable Non-Small Cell Lung Cancer

The Methodist Hospital Research Institute

Phase 1 Recruiting
15 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00178113 2015-05-27

A Pilot Study of Lycopene Supplementation in Prostatic Intraepithelial Neoplasia

University of Pittsburgh

Phase 1 Completed
80 enrolled
Genitourinary

Prostatic Intraepithelial Neoplasia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡